Inovio Pharmaceuticals
INO
₹148.25
Share price
-1.70%
Change (1 day)
-87.19%
Change (1 year)
Categories
Operating Margin for Inovio Pharmaceuticals (INO)
Operating Margin as of March 2025 (TTM): -49,254.30%
According to Inovio Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -49,254.30%. At the end of 2024 the company had an Operating Margin of -49,254.27%.
Operating Margin history for Inovio Pharmaceuticals from 2001 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -49,254.27% | 203.29% |
| 2023 | -16,239.87% | 500.24% |
| 2022 | -2,705.57% | -84.16% |
| 2021 | -17,085.39% | 677.35% |
| 2020 | -2,197.89% | -25.19% |
| 2019 | -2,938.01% | 844.71% |
| 2018 | -311.00% | 48.86% |
| 2017 | -208.92% | 0.2% |
| 2016 | -208.49% | 171.12% |
| 2015 | -76.90% | -77.75% |
| 2014 | -345.61% | -29.57% |
| 2013 | -490.69% | 2.52% |
| 2012 | -478.63% | 206.34% |
| 2011 | -156.24% | -45.57% |
| 2010 | -287.06% | 87.56% |
| 2009 | -153.04% | -76.5% |
| 2008 | -651.14% | 96.91% |
| 2007 | -330.68% | -14.07% |
| 2006 | -384.82% | 72.81% |
| 2005 | -222.69% | -77.42% |
| 2004 | -986.27% | -88.03% |
| 2003 | -8,237.11% | 164.23% |
| 2002 | -3,117.36% | 2427.62% |
| 2001 | -123.33% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | 12.60% | -100.03% | 🇺🇸 USA |
 | 18.78% | -100.04% | 🇺🇸 USA |
 | -17,247.50% | -64.98% | 🇺🇸 USA |
 | 26.37% | -100.05% | 🇨🇭 Switzerland |
 | 31.06% | -100.06% | 🇺🇸 USA |
 | 10.93% | -100.02% | 🇬🇧 UK |
 | 2.39% | -100.00% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.